Login

Andrew Sudholz, CEO, Japara Healthcare Ltd 00:00:00

Share On Facebook Share On Twitter

Andrew Sudholz, CEO, Japara Healthcare Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Aston Minerals (ASO) Emerges as a Key Player in the ASX Nickel Sector with Robust Resource Estimates at Edleston | Tolga Kumova, Chairman, Aston Minerals Ltd.
00:10:00
The Demands and Realities of CEO Leadership | Strauss Zelnick, Founder, Zelnick Media Capital.
00:00:00
Emerging class of drugs for the treatment of chronic and age-related diseases - JOSEPH J. SARRET, M.D., J.D. Chief Executive Officer and Director, CohBar Inc
00:10:00
Global and Local Investment Insights with Justin Hyland and Will Hickson | Justin Hyland, Managing Director, Hyland Financial Planning.
00:10:00
Guiding You Through the Complexities of Retirement Planning
00:10:00
Horace Mann CEO Marita Zuraitis and Springfield Public Schools present the 2018 Administrator of the Year award.
00:10:00
South Harz Potash: Overview and Investment Potential
00:10:00
building deep tech companies powered by material science innovations|Carmichael Roberts,Managing Partner,Material Impact Fund
00:10:00
Cardinal Energy Limited ASX:CE1 - A few words from Chairman, Glenn Whiddon | M. Scott Ratushny, CEO, Cardinal Energy Ltd (Alberta)CJ:TOR
00:10:00
A conversation with Civmec Ltd's higher-up | Patrick John Tallon, CEO, Civmec LtdP9D:SES
00:10:00
Finding the Best Investment Strategy for You | Adam Taylor, CEO, Taylor Financial.
00:10:00
Sean Trauschke, newly appointed CEO of OGE Energy Corp., discusses his past positions and future plans in an interview.

© 2017 - Neuhu+